BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  ImmunityBio Reports Record Q1 2026 Results: Net Product Revenue Increased Nearly 2.7x Year-Over-Year to $44 Million in Q1 2026 Expanding on the 2025 Full Year 700% Year-Over-Year Revenue Growth; Cash and Marketable Securities Total $381 Million

  May 7, 2026

   · 

  14 min read
• Press Releases

  Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

  May 7, 2026

   · 

  15 min read
• Press Releases

  Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates

  May 7, 2026

   · 

  8 min read
• Press Releases

  InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

  May 7, 2026

   · 

  10 min read
• Press Releases

  Restart Life Sciences Appoints Capital Markets Veteran Lindsay Hamelin to Board of Directors

  May 7, 2026

   · 

  5 min read
• 

  FDA

  Sanofi requests removal of Tzield from CNPV program after Høeg gets involved

  Acting Center for Drug Evaluation and Research Director Tracy Beth Høeg reportedly disagreed with staff who wanted to approve Sanofi’s type 1 diabetes drug. It’s far from the first time a political appointee has allegedly meddled in a recent FDA decision.

  May 7, 2026

   · 

  4 min read

   · 

  Heather McKenzie
• Press Releases

  AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential

  May 7, 2026

   · 

  6 min read
• Press Releases

  ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals

  May 7, 2026

   · 

  4 min read
• Press Releases

  Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

  May 7, 2026

   · 

  11 min read
• Press Releases

  ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results

  May 7, 2026

   · 

  1 min read